The impact of implementing an antifungal stewardship with monitoring of 1-3, β-D-glucan values on antifungal consumption and clinical outcomes.
Syuri Ito-TakeichiTakashi NiwaAyasa FujibayashiKeiko SuzukiHirotoshi OhtaAyumi NiwaMayumi TsuchiyaMasayo YamamotoDaijiro HatakeyamaAkio SuzukiHisashi BabaNobuo MurakamiYoshinori ItohPublished in: Journal of clinical pharmacy and therapeutics (2019)
Our findings suggest that daily review of the use of antifungal agents and monitoring of measured βDG values was highly effective in reducing antifungal consumption and improving the clinical outcomes of patients with Candida bloodstream infection.